NCT02620345

Fibroids in Women of Reproductive Age and Women Pregnancy

Uterine Fibroids Are a Very Common Finding in Women of Reproductive Age. Ready Safety Study Dydrogesterone + Multivitamin Nature in Women of Reproductive Age and Women Pregnancy

• Status: Completed
• Phase: Phase 4
• Study type: Interventional
• Enrollment: 22 (actual)
• Sponsor: Trieu, Nguyen Thi, M.D. · Individual
• Sex: Female
• Age: 18 Years – 35 Years
• Healthy volunteers: Accepted

Summary

Dydrogesterone Multivitamin Nature treatment of fibroids in women of reproductive age and women pregnancy to lost the size fibroids.

Detailed description

Uterine fibroids are a very common finding in women of reproductive age. But may fibroids grow in the first trimester pregnancy. Clinically has shown that: Uterine fibroids are associated with an Heavy or prolonged menstrual periods. Abnormal bleeding between menstrual periods. Uterine fibroids are associated with an increased rate of spontaneous miscarriage, preterm labor, placenta abruption, malpresentation, labor dystocia, cesarean delivery, and postpartum hemorrhage, pain is the most common complication of fibroids during pregnancy. Can usually be controlled by conservative treatment on Dydrogesterone Multivitamin nature.

Conditions

• Fibroids

Interventions

Type	Name	Description
DRUG	Dydrogesterone M ( case 1 )	Dydrogesterone Multivitamin nature * Fibroids / Women Pregnancy ( discovered fibroids during pregnancy ) Dydrogesterone Multivitamin nature. * 1tablet/24 hours/day (to 4 weeks after postpartum)
DRUG	Dydrogesterone M ( case 2 )	Dydrogesterone Multivitamin nature * Fibroids/ Women of Reproductive age ( discovered fibroids ) * 1tablet/24 hours/day ( from discovered fibroids through 6 months)

Timeline

• Start date: 2010-01-01
• Primary completion: 2015-10-01
• Completion: 2015-11-01
• First posted: 2015-12-03
• Last updated: 2015-12-03